- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr. Michelle Melisko Discusses Access to Care for Breast Cancer Patients
Dr. Michelle E. Melisko, Assistant Clinical Professor, UCSF, Helen Diller Family Comprehensive Cancer Center, explains how drug shortages are affecting patients with breast cancer and the potential impact to cost and outcomes.
doxorubicin Hcl Liposome Injection
doxorubicin),
Dr. Melisko discusses the paclitaxel (Brand name: Taxol) shortages that have impacted the ability to start patients with clinical trials. Physiscians are being asked to prescribe alternative drugs and only use Taxol when absolutely necessary. A recommended alternate to Taxol is another albumin-bound paclitaxel; however, it is costly. Doxil () has been a more serious shortage since the middle of August. Patients were able to switch to Adriamycin (which has more toxicity and side affects. However, Dr. Melisko does not feel it will necessarily impact the long-term prognosis because there are other drugs to be given. It is stressful for the patients and physicians to not be able to rely on using a specific drug.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
